Hugo Fry
| Hugo Fry | |
| Occupation | Co-founder and Chief Scientific Officer, Mecha Health |
|---|---|
| Known for | Co-founding Mecha Health |
Hugo Fry is a British entrepreneur and co-founder and Chief Scientific Officer of Mecha Health, an applied artificial intelligence company that develops foundation models to automate x-ray analysis for radiologists. The company participated in Y Combinator's Winter 2025 batch and is based in San Francisco.[1]
Career
Prior to founding Mecha Health, Fry was involved in the biotechnology sector. He served as CEO of RQ Bio, a biotechnology startup focused on developing antibodies for vulnerable populations exposed to infectious diseases. He has also been associated with other ventures in the life sciences and pharmaceutical industries.
Fry co-founded Mecha Health, which builds proprietary foundation models designed to process medical images and generate accurate draft radiology reports. According to the company, its first model was developed in under two months and outperformed models from Microsoft, Google, and OpenAI on clinical accuracy metrics, while being two orders of magnitude smaller and trained on a quarter of the data.[1]
The company's system ingests medical images in standard formats such as DICOM, HL7, and FHIR, and produces complete structured radiology reports in seconds. Mecha Health states that its technology is intended to enable radiologists to increase their throughput from reading approximately one scan per hour to one scan every five minutes. The company operates on a per-scan pricing model and identifies x-ray report generation as a market opportunity exceeding $40 billion.[1]
Mecha Health has partnered with what it describes as the largest privately owned radiology practice in the United States, as well as a multinational tele-radiology company, to deploy custom foundation models for their radiologists.
In 2025, the company announced it had raised $4.1 million in seed funding. The round was led by Valia Ventures, with participation from Y Combinator, Rebel Fund, Reach Capital, and Phosphor Capital.[2]
As of early 2026, Mecha Health had approximately four employees. Fry serves as the company's Chief Scientific Officer, overseeing its technical and research efforts in areas including machine learning, computer vision, and vision-language models.
Outside of his professional career, Fry is a competitive marathon runner. He has competed in the London Marathon and the Berlin Marathon.
References
- ↑ 1.0 1.1 1.2 "Mecha Health – Y Combinator". 'Y Combinator}'. Retrieved 2026-03-18.
- ↑ "Mecha Health". 'Mecha Health}'. Retrieved 2026-03-18.